Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vocabulary Change: CDER Eliminating 'Review' For NDAs And BLAs
Apr 16 2019
•
By
Derrick Gingery
A review by any other name would smell as sweet.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet